Pharmacological Profile of Quinoxalinone

about

Synthesis and structure elucidation using 2D NMR and thermal coefficient investigation on amino acid tethered quinoxalines.Silver-catalyzed decarboxylative acylation of quinoxalin-2(1H)-ones with α-oxo-carboxylic acids.

P2860

Q46516174-9AAD1A9E-AFB4-47FC-8A1D-69EA0B550B0F Q50078850-B5D8B664-1391-45B9-8ECC-78FC41AC2D82

P2860

Pharmacological Profile of Quinoxalinone

Item

http://www.wikidata.org/entity/Q59054635

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2014

@uk

name

Pharmacological Profile of Quinoxalinone

@en

Pharmacological Profile of Quinoxalinone

@nl

type

Item

label

Pharmacological Profile of Quinoxalinone

@en

Pharmacological Profile of Quinoxalinone

@nl

prefLabel

Pharmacological Profile of Quinoxalinone

@en

Pharmacological Profile of Quinoxalinone

@nl

P1476

Pharmacological Profile of Quinoxalinone

@en

P2093

Ahmed Moussaif

http://www.w3.org/2001/XMLSchema#string

El Mokhtar Essassi

http://www.w3.org/2001/XMLSchema#string

Khalid Karrouchi

http://www.w3.org/2001/XMLSchema#string

Youssef Ramli

http://www.w3.org/2001/XMLSchema#string

P2860

Synthesis and SAR of novel tricyclic quinoxalinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1)

Imidazo[1,5-a]quinoxalines as irreversible BTK inhibitors for the treatment of rheumatoid arthritis

Activity of a novel quinoxaline derivative against human immunodeficiency virus type 1 reverse transcriptase and viral replication

Quinoxaline chemistry. Part 13: 3-Carboxy-2-benzylamino-substituted quinoxalines and N-[4-[(3-carboxyquinoxalin-2-yl) aminomethyl]benzoyl]-L-glutamates: synthesis and evaluation of in vitro anticancer activity

Preclinical evaluation of HBY 097, a new nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 replication

Structure-activity studies of substituted quinoxalinones as multiple-drug-resistance antagonists.

Synthetic inhibitors of thrombin and factor Xa: from bench to bedside.

A novel potential therapeutic avenue for autism: design, synthesis and pharmacophore generation of SSRIs with dual action

A Potent and Selective Quinoxalinone-Based STK33 Inhibitor Does Not Show Synthetic Lethality in KRAS-Dependent Cells.

Inhibitors of multidrug resistance to antitumor agents (MDR).

P304

1-21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2014/563406

http://www.w3.org/2001/XMLSchema#string

P478

2014

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P921

Farmakologi

Pharmacological Profile of Quinoxalinone

about

P2860

P2860

Pharmacological Profile of Quinoxalinone

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P921